Japanese Journal of Clinical Oncology 19:242-248 (1989)
© 1989 Foundation for Promotion of Cancer Research
research-article |
Comparison of Serum Assays for TAG-72, CA19-9 and CEA in Gastrointestinal Carcinoma Patients
1Second Department of Surgery, Tohoku University School of Medicine 1-1 Seiryo-machi, Sendai 980
2Clinical Laboratory 3-1 Shimizukoji, Sendai 980
3Department of Surgery, Sendai City Hospital 3-1 Shimizukoji, Sendai 980
4Toray-Fuji Bionics, Inc 9-14 Nishiki 2-Chome, Nerima-ku, Tokyo 176
*For reprints and all correspondence
Received January 9, 1989; accepted March 31, 1989
Tumor-associated glycoprotein (TAG-72) has been shown to be expressed in a wide variety of epithelial malignant tissues. We have investigated serum levles of TAG-72 antigen in patients with gastrointestinal cancer with a solid phase radioimmunometric assay (RIA), CA72-4, utiliz ing murine monoclonal antibodies CC49 and B72.3 which recognize the TAG-72 antigen. Elevated levels of serum TAG-72 antigen were found in 48% of 56 gastric carcinoma patients and 67% of 45 colorectal carcinoma patients. The serum concentrations of TAG-72 were compared to those of CA19-9 and CEA. The positive rates of CA19-9 in gastric carcinoma and colorectal carcinoma patients were 29% and 54%, and those of CEA were 52% and 60%, respectively. Elevated serum levels of TAG-72, CA19-9 and CEA were observed in 7%, 14% and 24%, respectively, of patients with benign disease, thus indicating a preferential expression of TAG-72, compared to CA19-9 and CEA, in gastrointestinal carcinoma patients versus in patients with benign disorder. A cocktail of CA72-4, CA19-9 and CEA RIAs increased positive rates to 68% in sera of gastric cancer patients and 84% in sera of colorectal cancer patients. Combination as says using CA72-4, CEA and CA19-9 RIM for patients with benign gastrointestinal disorder, however, also increased the positive rate to 31%. These results indicate that CA72-4, CA19-9 and CEA RIA may be complementary in detecting circulating tumor-associated antigens. It must be emphasized, however, that interpretation of the data provided by the combination serum as says requires careful consideration.
Key Words: Tumor-associated antigen • Carcinoembryonic antigen • Monoclonal antibody • Radioimmunometric assay
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-d. Chen, S. Zheng, J.-k. Yu, and X. Hu Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy Population Clin. Cancer Res., December 15, 2004; 10(24): 8380 - 8385. [Abstract] [Full Text] [PDF]
|
|